Ignite Creation Date:
2025-12-24 @ 3:17 PM
Ignite Modification Date:
2026-01-02 @ 6:55 AM
Study NCT ID:
NCT01607892
Status:
COMPLETED
Last Update Posted:
2023-01-26
First Post:
2012-05-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer
Sponsor:
Karyopharm Therapeutics Inc
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hematological Malignancies | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Selinexor | View |
| None | KPT-330 | View |
| None | Multiple Myeloma | View |
| None | non-Hodgkin Lymphoma | View |
| None | Chronic Lymphocytic Leukemia | View |
| None | Waldenström's macroglobulinemia | View |
| None | Peripheral T-Cell Lymphoma | View |
| None | Cutaneous T-Cell Lymphoma | View |
| None | Chronic Myelocytic Leukemia | View |
| None | Acute Lymphoblastic Leukemia | View |